<DOC>
	<DOCNO>NCT01288066</DOCNO>
	<brief_summary>The clinical question whether replace glenoid component patient degenerative shoulder disease , answer yet randomize study enough statistical power . In study , patient randomly allocate treatment hemi- total shoulder arthroplasty use implant Epoca system . The primary objective comparison pain function treatment group 5 year use Constant score .</brief_summary>
	<brief_title>Effectiveness Hemi- Versus Total Shoulder Arthroplasty Using Implants `` Epoca '' System</brief_title>
	<detailed_description>Shoulder arthroplasty accept treatment choice improve function minimum pain well-selected patient . A persistent discussion remain whether replacement glenoid ( ie , total arthroplasty ) perform . Possible advantage glenoid replacement include decrease pain compare hemiarthroplasty metal-on-bone articulation , increase stability due conform glenoid component , lateralization joint center provide improved range motion abduction strength . Potential complication glenoid replacement implant loosening loss glenoid bone stock . If hemiarthroplasty perform , glenoid replacement relate complication avoid . In addition , hemiarthroplasty require less surgical time less expensive total shoulder arthroplasty . To date , evidence answer clinical question whether replace glenoid component patient degenerative shoulder disease . In study , stem Epoca humeral component ( Epoca Stem ) Epoca Resurfacing Head ( Epoca RH ) include . While stemmed prosthesis develop nonreconstructable fracture omarthroses , humeral resurface head implant design specifically use degenerative disease shoulder joint . This randomized multicenter study aim compare efficacy hemi versus total shoulder arthroplasty use Epoca RH Epoca Stem patient degenerative joint disease . The primary aim present study demonstrate Constant score assess shoulder function pain high patient group treat total arthroplasty compare hemiarthroplasty group 5 year . The secondary aim study assess difference Shoulder Pain Disability Index ( SPADI ) , duration surgery , rate local general adverse event relationship device treatment investigation , survivorship implant , quality life 6 month , 1 , 3 5 year treatment group .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>Age 18 year old Primary secondary omarthrosis ( eg , rheumatoid arthritis , avascular head necrosis ) Glenoid morphologic type A1 , A2 B1 accord Walch Ability understand content patient information / inform consent form participate clinical investigation Written inform consent Preoperative : Posttraumatic omarthrosis Biconcave aspect glenoid ( Walch type B2 ) Retroversion glenoid 25Â° ( Walch type C ) `` Epoca Reko '' prosthesis Humerus fracture Patients severe systemic disease : class IIIIV accord American Society Anaesthesiologists physical status classification ( ASA ) Substance abuse would preclude reliable assessment Pregnancy Prisoners Participation medical device medicinal product study within previous month could influence result present study Intraoperative : Full thickness tear rotator cuff Indication hemiarthroplasty Indication total arthroplasty Intraoperative decision use implant Epoca</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Shoulder</keyword>
	<keyword>Total arthroplasty</keyword>
	<keyword>Hemiarthroplasty</keyword>
	<keyword>Resurfacing</keyword>
	<keyword>Glenoid</keyword>
	<keyword>Constant score</keyword>
</DOC>